⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5049163 | 0.97 | FDPS (0.56) | — | |
| SCHEMBL38697 | 0.84 | FDPS (0.50) | — | |
| SCHEMBL3823200 | 0.84 | FDPS (0.50) | — | |
| Triphosphate SCHEMBL6675808 | 0.84 | FDPS (0.50) | — | |
| SCHEMBL15239278 | 0.84 | FDPS (0.50) | — | |
| Pyrophosphoric Acid SCHEMBL28447258 | 0.81 | FDPS (0.77) | — | |
| Pyrophosphoric Acid SCHEMBL29182570 | 0.81 | FDPS (0.91) | — | |
| SCHEMBL8672235 | 0.79 | FDPS (0.41) | — | |
| SCHEMBL936042 | 0.79 | FDPS (0.60) | — | |
| SCHEMBL333912 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217126-A1 | POLYNUCLEOTIDES, 3' CHAIN TERMINATING TAILS, LIGATION AND USES THEREOF | CONVERGENCE BIO, INC. (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4590683-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | Bristol-Myers Squibb Company (US) | 2025-07-30 | — | — | EP | claimed |
| WO-2024215515-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-10-17 | — | — | WO | claimed |
| US-20240165242-A1 | PRO-CYCLIC DINUCLEOTIDES AND PRO-CYCLIC DINUCLEOTIDE CONJUGATES FOR CYTOKINE INDUCTION | INVIVOGEN (FR) | 2024-05-23 | — | — | US | claimed |
| US-20240166675-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY | 2024-05-23 | — | — | US | claimed |
| WO-2024064638-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-03-28 | — | — | WO | claimed |
| EP-4289414-A1 | TISSUE PROTECTIVE HYDROGEL | ETH Zürich (CH) | 2023-12-13 | — | — | EP | claimed |
| US-11730817-B2 | Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction | INVIVOGEN (FR) | 2023-08-22 | — | — | US | claimed |
| WO-2023081485-A1 | STEPWISE SEQUENCING OF A POLYNUCLEOTIDE WITH A HOMOGENOUS REACTION MIXTURE | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| US-20230116913-A2 | PRO-CYCLIC DINUCLEOTIDES AND PRO-CYCLIC DINUCLEOTIDE CONJUGATES FOR CYTOKINE INDUCTION | INVIVOGEN (FR) | 2023-04-13 | — | — | US | claimed |
| EP-1381694-A1 | METHODS FOR IDENTIFYING LIGAND BINDING SITES IN A BIOMOLECULE | ISIS Pharmaceuticals, Inc. (US) | 2004-01-21 | — | — | EP | claimed |
| US-6653067-B1 | Contacting with modified/unmodified test molecule and dissociating; comparing the unseparated complexes; mass spectrometry; use in drug discovery | ISIS PHARMACEUTICALS, INC. | 2003-11-25 | — | — | US | claimed |
| US-20030165915-A1 | Methods for identifying ligand binding sites in a biomolecule | ISIS PHARMACEUTICALS, INC. | 2003-09-04 | — | — | US | claimed |
| US-20030077630-A1 | Methods for identifying ligand binding sites in a biomolecule | ISIS PHARMACEUTICALS, INC. | 2003-04-24 | — | — | US | claimed |
| US-20030013113-A1 | Methods for identifying ligand binding sites in a biomolecule | ISIS PHARMACEUTICALS, INC. | 2003-01-16 | — | — | US | claimed |
| WO-2002068691-A1 | METHODS FOR IDENTIFYING LIGAND BINDING SITES IN A BIOMOLECULE | ISIS PHARMACEUTICALS, INC. (US) | 2002-09-06 | — | — | WO | claimed |
| EP-0695170-A4 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNAT (US) | 1998-08-19 | — | — | EP | claimed |
| EP-0743318-A1 | NOVEL ANTI-HIV AGENT | KAJI, Akira (JP) | 1996-11-20 | — | — | EP | claimed |
| EP-0695170-A1 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNATIONAL L.P. (US) | 1996-02-07 | — | — | EP | claimed |
| WO-1994023699-A1 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNATIONAL L.P. (US) | 1994-10-27 | — | — | WO | claimed |